TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Yang, Li, Pang, Yanli, Moses, Harold L.·2010·Trends in Immunology
DOI 10.1016/j.it.2010.04.002

Cited by (1,000)

Items 601–700 of 1,000

  1. Bone morphogenetic proteins, activins, and growth and differentiation factors in tumor immunology and immunotherapy resistance
    Shonik Ganjoo, Nahum Puebla‐Osorio, Selene Nanez, Ethan Y. Hsu, Tiffany A. Voss, Hampartsoum B. Barsoumian, Lisa K. Duong, James William Welsh, María Angélica Cortez · 2022 · Frontiers in Immunology
  2. Integrated analysis of single-cell and bulk RNA sequencing data reveals an immunostimulatory microenvironment in tumor thrombus of osteosarcoma
    Tao Ji, Qianyu Shi, Song Mei, Jiuhui Xu, Haijie Liang, Lu Xie, Tingting Ren, Kunkun Sun, Dasen Li, Xiaodong Tang et al. · 2023 · Oncogenesis
  3. Activin A/ACVR2A axis inhibits epithelial‐to‐mesenchymal transition in colon cancer by activating SMAD2
    Hui Zhang, Qiang Ruan, Changjiang Chen, Hui Yu, Shen Guan, Dan Hu, Chunkang Yang, Ruirong Lin, Changhua Zhuo · 2023 · Molecular Carcinogenesis
  4. MicroRNAs and cardiac fibrosis: A comprehensive update on mechanisms and consequences
    Zekihan Gocer, Alperen Elek, Halil Caska, İbrahim Bozgeyik · 2023 · Pathology - Research and Practice
  5. Molecular heterogeneity in histomorphologic subtypes of lung adeno carcinoma represents a challenge for treatment decision
    Tobias Kolb, Sarah Müller, Peter Möller, Thomas F.E. Barth, Ralf B. Marienfeld · 2024 · Neoplasia
  6. Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma
    Jiong Li, Wendi Wang, Sang Li, Zhengkang Qiao, Haoyue Jiang, Xinyue Chang, Ya-Ning Zhu, Hongpei Tan, Xiaoqian Ma, Yuqian Dong et al. · 2024 · Cancer Cell International
  7. Targeting TGFβ with chimeric switch receptor and secreted trap to improve T cells anti-tumor activity
    Tatyana Matikhina, Cyrille J. Cohen · 2024 · Frontiers in Immunology
  8. Carbohydrate sulfation as a critical modulator of siglec-sialoglycan interactions
    Jaesoo Jung, Edward N. Schmidt, Matthew Scott Macauley · 2025 · Carbohydrate Research
  9. The role of transforming growth factor beta in thyroid autoimmunity: current knowledge and future perspectives
    Efstratios Kardalas, Evangelos Grigoriou Sakkas, Marek A. Ruchała, Djuro Μacut, George P. Mastorakos · 2021 · Reviews in Endocrine and Metabolic Disorders
  10. Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma
    Qian Yu, Liang Zhao, Xuexin Yan, Li Ye, Xinyu Chen, Xiaohua Hu, Qing Bu, Xiaoping Lv · 2022 · World Journal of Surgical Oncology
  11. Immunostimulant nanomodulator boosts antitumor immune response in triple negative breast cancer by synergism of vessel normalization and photothermal therapy
    Hao Jiang, Yilang He, Jia Zhao, Ruimin Chang, Hailun He, Tan Li, Xingyu Zhang, Bo Shu, Wenxuan Zhang, Huaiyu Wang et al. · 2023 · Nano Research
  12. Clinical and laboratory patterns during immune stimulation in hormone responsive metastatic breast cancer
    Andrea Nicolini, Giuseppe Rossi, Paola Ferrari, Angelo Carpi · 2013 · Biomedicine & Pharmacotherapy
  13. Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells
    Guoxiang Liu, Xiaohui Xu, Liangqian Jiang, Huanhuan Ji, Feng Zhu, Bingnan Jin, Jingjing Han, Xiaolei Dong, Fanghao Yang, Bing Li · 2020 · Frontiers in Pharmacology
  14. Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression
    Hiroto Takeuchi, Satoru Konnai, Naoya Maekawa, Satoshi Takagi, Hiroshi Ohta, Noboru Sasaki, Sangho Kim, Tomohiro Okagawa, Yasuhiko Suzuki, Shiro Murata et al. · 2021 · Frontiers in Veterinary Science
  15. CCL25 Signaling in the Tumor Microenvironment
    Hina Mir, Shailesh Singh · 2021 · Advances in experimental medicine and biology
  16. Calcium ions promote primary renal epithelial cell differentiation into cells with bone-associated phenotypes via transforming growth factor-β1-induced epithelial-mesenchymal transition in idiopathic hypercalciuria patients
    Deng He, Shaogang Wang, Zhaohui Jia, LEI CUI, Yuchao Lu, Henglong Hu, Baolong Qin · 2014 · Molecular Medicine Reports
  17. TGF-β signaling pathways in cancers
    Beata Talar, Małgorzata Czyż · 2013 · Postępy Higieny i Medycyny Doświadczalnej
  18. Dynamics of cell-type transition mediated by epigenetic modifications
    Rongsheng Huang, Qiaojun Situ, Jinzhi Lei · 2023 · Journal of Theoretical Biology
  19. Recent Progress on Nanomedicine‐Mediated Repolarization of Tumor‐Associated Macrophages for Cancer Immunotherapy
    Jingyang Zhang, Ying Su, Xu Wang, Xueqing Yao, Jin‐Zhi Du · 2024 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
  20. Co‐Expression of Dominant‐Negative TGF ‐β Receptor 2 Enhances the Therapeutic Efficacy of Novel TREM1 / DAP12 ‐ BB ‐Based CAR ‐T Cells in Solid Tumours
    Sichao Zhu, Jianping Hu, Jie Lin, Chen Wang, Enxiu Wang · 2025 · Immunology
  21. TGF-β signaling in the ovary: Emerging roles in development and disease
    Yuxu He, Mailin Gan, Jianfeng Ma, Shuang Liang, Lei Chen, Lili Niu, Ye Zhao, Yan Wang, Li Xin Zhu, Linyuan Shen · 2025 · International Journal of Biological Macromolecules
  22. Developing an effective breast cancer vaccine: Challenges to achieving sterile immunity versus resetting equilibrium
    Giuseppe Curigliano, Carmen Criscitiello, Angela Espósito, Luca A. M. Fumagalli, Lucia Gelao, Marzia Locatelli, Ida Minchella, Aron Goldhirsch · 2013 · The Breast
  23. Role of the microenvironment in the tumourigenesis of microsatellite unstable and MUTYH-associated polyposis colorectal cancers
    Noel F.C.C. de Miranda, Frederik Jan Hes, Tom van Wezel, Hans M. Morreau · 2012 · Mutagenesis
  24. MicroRNA-329 serves a tumor suppressive role in colorectal cancer by directly targeting transforming growth factor beta-1
    Baohuan Li, Miaomiao Huang, Meiying Liu, Shiling Wen, Fang Sun · 2017 · Molecular Medicine Reports · Retracted
  25. Bispecific antibodies in acute lymphoblastic leukemia therapy
    Guranda Chitadze, Anna Laqua, Marcus Lettau, Claudia Dorothea Baldus, Monika Brüggemann · 2020 · Expert Review of Hematology
  26. Radiation-Induced Bystander Effect: Loss of Radioprotective Capacity of Rosmarinic Acid In Vivo and In Vitro
    Amparo Olivares, Miguel Alcaraz-Saura, Daniel Gyingiri Achel, Juan de Dios Berná-Mestre, Miguel Alcaraz · 2021 · Antioxidants
  27. Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma
    Katherine Elizabeth Masih, Jun Wei, David Milewski, Javed Mohammed Khan · 2021 · Journal of Cellular Immunology
  28. Inhibition of protein arginine methyltransferase 1 alleviates liver fibrosis by attenuating the activation of hepatic stellate cells in mice
    Fang‐Zhi Yan, Hui Qian, Fang Liu, Chen‐Hong Ding, Shu‐Qing Liu, Meng‐Chao Xiao, Shijie Chen, Xin Zhang, Cheng Luo, Wei‐Fen Xie · 2022 · The FASEB Journal
  29. Highly tough and elastic microspheric gel for transarterial catheter embolization in treatment of liver metastasis tumor
    Shuyun Wang, Hongjie Yu, Guangsheng Wan, Haowei Fang, Jinxia Mi, Wenqian Xu, Kexiang Sun, Kunxi Zhang, Jingbo Yin, Wanli Deng · 2023 · Regenerative Biomaterials
  30. Spontaneous Mesotheliomas in F344/N Rats Are Characterized by Dysregulation of Cellular Growth and Immune Function Pathways
    Pamela E. Blackshear, Arun R. Pandiri, Thai-Vu T. Ton, Natasha P. Clayton, Keith R. Shockley, Shyamal D. Peddada, Kevin Gerrish, Robert C. Sills, Mark James Hoenerhoff · 2013 · Toxicologic Pathology
  31. Current status and future prospects of transforming growth factor‐β as a potential prognostic and therapeutic target in the treatment of breast cancer
    Forouzan Amerizadeh, Afsane Bahrami, Majid Khazaei, AmirReza Hesari, Majid Rezayi, Sahar Talebian, Mona Maftouh, Mehrdad Moetamani‐Ahmadi, Sima Seifi, Soodabeh Shahidsales et al. · 2019 · Journal of Cellular Biochemistry
  32. Regulatory role of the transforming growth factor-β signaling pathway in the drug resistance of gastrointestinal cancers
    Xiaoqun Lv, Guoxiong Xu · 2021 · World Journal of Gastrointestinal Oncology
  33. Characterization of surgical models of postoperative tumor recurrence for preclinical adjuvant therapy assessment.
    Jarrod D. Predina, Brendan F. Judy, Veena Kapoor, Aaron Blouin, Louis A Aliperti, Daniel Levine, Olugbenga T. Okusanya, Jon G. Quatromoni, Zvi G. Fridlender, Sunil Kumar Singhal · 2012 · Europe PMC (PubMed Central)
  34. CD103+ Cell Growth Factor Flt3L Enhances the Efficacy of Immune Checkpoint Blockades in Murine Glioblastoma Model
    Xiaolin Miao, Yiqi Chen, Ke Hao, Meiqin Zheng, Bingyu Chen, Kaiqiang Li, Ying Wang, Wei Zhang, Yu Zhang, Xiaozhou Mou et al. · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  35. Notch-Induced Myeloid Reprogramming in Spontaneous Pancreatic Ductal Adenocarcinoma by Dual Genetic Targeting
    Phyllis F. Cheung, Florian Neff, Christian Neander, Anna Bazarna, Konstantinos Savvatakis, Sven‐Thorsten Liffers, Kristina Althoff, Chang‐Lung Lee, Everett James Moding, David G. Kirsch et al. · 2018 · Cancer Research
  36. Tumor Microenvironment Onmyoji: Cytokines with Dual Protumor and Antitumor Roles
    Yaxuan Wang, Anqi Lin, Zaoqu Liu, Quan Cheng, Jian Zhang, Peng Luo · 2026 · 癌症：英文版
  37. Efficacy of combined tumor irradiation and KCa3.1-targeting with TRAM-34 in a syngeneic glioma mouse model
    Nicolai Stransky, Katrin Ganser, Leticia Quintanilla‐Martínez, Irene González-Menéndez, Ulrike Naumann, Franziska Eckert, Pierre Koch, Stephan M. Huber, Peter Ruth · 2023 · Scientific Reports
  38. Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer
    Ziang Chen, Yuxi Ou, Fangdie Ye, Weijian Li, Haowen Jiang, Shenghua Liu · 2024 · Journal of Cancer Research and Clinical Oncology
  39. The reactive stroma response regulates the immune landscape in prostate cancer
    Rintu Thomas, J. M. Jerome, Kimiko L. Krieger, Naghmana Ashraf, David R. Rowley · 2024 · Journal of Translational Genetics and Genomics
  40. Genomic biology and therapeutic strategies of liver metastasis from gastric cancer
    Yichao Wang, Guangyu Ding, Chu Chu, Xiangdong Cheng, Jiang‐Jiang Qin · 2024 · Critical Reviews in Oncology/Hematology
  41. Locoregional therapies combined with immune checkpoint inhibitors for liver metastases
    Xingchen Zhang, Yuwen Zhou, Gui-Xia Wei, Yiqiao Luo, Meng Qiu · 2024 · Cancer Cell International
  42. Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
    Yuichi Ozawa, Yasuhiro Koh, Ryota Shibaki, Yuhei Harutani, Hiroaki Akamatsu, Atsushi Hayata, Takeya Sugimoto, Yuka Kitamura, Junya Fukuoka, Masanori Nakanishi et al. · 2024 · Cancer Immunology Immunotherapy
  43. Melatonin augments anti-tumor activity and alleviates nephrotoxicity of gemcitabine in a pancreatic cancer xenograft model targeting P62/Keap1 pathway
    Samar Ibrahim, Eman H. Yousef, Ahmed M. El‐Dessouki, Nahed A. Raslan, Amany A. Alzokaky · 2025 · Naunyn-Schmiedeberg s Archives of Pharmacology
  44. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium
    Georgia Chenevix‐Trench, Jieping Lei, kConFab Investigators, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning et al. · 2015 · Human Genetics
  45. RNA interference provides insights into the multi-functional profiles of Es-MSTN gene in Eriocheir sinensis
    Wucheng Yue, He Yang, Yipei Chen, Jun Wang, Xiaowen Chen, Xin Hou, Hua Han, Chenghui Wang · 2020 · Aquaculture Reports
  46. Oncolyic Virotherapy for Prostate Cancer: Lighting a Fire in Winter
    Gongwei Wang, Ying Liu, Shuoru Liu, Yuan Lin, Cheng Ping Hu · 2022 · International Journal of Molecular Sciences
  47. Does the expression of the ACVR2A gene affect the development of colorectal cancer?
    Damian Wodziński, Agnieszka Wosiak, Jacek Pietrzak, Rafał Świechowski, Agnieszka Maria Jeleń, Ewa Izabela Balcerczak · 2019 · Genetics and Molecular Biology
  48. Administration of TGF-ß Inhibitor Mitigates Radiation-induced Fibrosis in a Mouse Model
    Itai Gans, Jad M. El Abiad, Aaron Watkins James, Adam Scott Levin, Carol D. Morris · 2020 · Clinical Orthopaedics and Related Research
  49. The Physical Microenvironment of Tumors: Characterization and Clinical Impact
    Matthew R. Zanotelli, Neil C. Chada, Christopher Andrew Johnson, Cynthia A. Reinhart‐King · 2020 · Biophysical Reviews and Letters
  50. Laser Immunotherapy: A Potential Treatment Modality for Keratinocyte Carcinoma
    Silje Haukali Omland, Emily Cathrine Wenande, Inge Marie Svane, Joshua Tam, Uffe H. Olesen, Merete Hædersdal · 2021 · Cancers
  51. Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of ATP1A2 on the TGF-β/Smad pathway
    Bashan Zhang, Zinian Zhu, Xibo Zhang, Fei Li, Aijiao Ding · 2022 · Translational Andrology and Urology
  52. Blocking Wnt as a therapeutic target in mice model of skin cancer
    Abdullah Alyoussef, Medhat Taha · 2019 · Archives of Dermatological Research
  53. Convergent evolution of p38/MAPK activation in hormone resistant prostate cancer mediates pro-survival, immune evasive, and metastatic phenotypes
    Kathryn E. Ware, Santosh K. Gupta, Jared Eng, Gabor Kemeny, Bhairavy J. Puviindran, Wen‐Chi Foo, Lorin A. Crawford, R. Garland Almquist, Daniella Runyambo, Beatrice C. Thomas et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  54. Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer
    Jayapradha Gnanagurusamy, Sneha Krishnamoorthy, Sridhar Muthusami · 2024 · International Immunopharmacology
  55. Extracellular Vesicles and Their Applications in Tumor Diagnostics and Immunotherapy
    Scott W. Strum, Valentina E. Evdokimova, Laszlo George Radvanyi, Anna Spreafico · 2024 · Cells
  56. Deciphering TGF-β1's role in drug resistance and leveraging plant bioactives for cancer therapy
    Vishal Kumar Deb, Nidhi Chauhan, Utkarsh Jain · 2024 · European Journal of Pharmacology
  57. Beyond the tumor region: Peritumoral radiomics enhances prognostic accuracy in locally advanced rectal cancer
    Zhiying Liang, Mao-Li Yu, Hui Yang, Haojiang Li, Hui Xie, Chun-Yan Cui, Weijing Zhang, Chao Luo, Peiqiang Cai, Xiaofeng Lin et al. · 2025 · World Journal of Gastroenterology
  58. Overcoming functional and translational challenges of cellular immunotherapies for solid tumors
    Yi-Ching Chen, Kok‐Siong Chen, Bruce L. Levine, Khalid Shah · 2026 · Cancer Cell
  59. Neutrophil programming dynamics and its disease relevance
    Taojing Ran, Shuo Geng, Liwu Li · 2017 · Science China Life Sciences
  60. REMOVED: Natural products as modulators of signaling in inflammation
    Muhammad Daniyal, Wei Wang · 2021 · Elsevier eBooks
  61. The Immunomodulatory Role of Hypoxic Tumor-Derived Extracellular Vesicles
    Joël E.J. Beaumont, Nicky A. Beelen, Lotte Wieten, Kasper M. A. Rouschop · 2022 · Cancers
  62. MAP3K19 Promotes the Progression of Tuberculosis-Induced Pulmonary Fibrosis Through Activation of the TGF-β/Smad2 Signaling Pathway
    Yu Xia, Haiyue Wang, Meihua Shao, Xuemei Liu, Feng Sun · 2023 · Molecular Biotechnology
  63. Regulation of epithelial-mesenchymal transition in retinal pigment epithelium and its associated cellular signaling cascades: an updated review
    Brijesh Gelat, Pooja B Malaviya, Pooja Rathaur, Krupali Trivedi, Priya Chaudhary, Binita Patel, Kaid Johar, Rahul Gelat · 2023 · Beni-Suef University Journal of Basic and Applied Sciences
  64. Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells
    Xunxian Liu, Yun-shang Piao, Julia T. Arnold · 2011 · Carcinogenesis
  65. Immunomodulatory Effects of TGF-β Family Signaling within Intestinal Epithelial Cells and Carcinomas
    Paula Marincola Smith, Anna L. Means, Robert Daniel Beauchamp · 2019 · Gastrointestinal Disorders
  66. Identification of novel TGF-β regulated genes with pro-migratory roles
    Qi Liu, Nicholas C. Borcherding, Peng Shao, Huojun Cao, Weizhou Zhang, Hank Heng Qi · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  67. Pan-Cancer Analysis and Validation Reveals that D-Dimer-Related Genes are Prognostic and Downregulate CD8+ T Cells via TGF-Beta Signaling in Gastric Cancer
    Yiming Guan, Bing Xu, Yi Sui, Zhezhou Chen, Yu Luan, Yan Jiang, Lijuan Wei, Wenjing Long, Sansan Zhao, Lei Han et al. · 2022 · Frontiers in Molecular Biosciences
  68. What Are the Roles of Proprotein Convertases in the Immune Escape of Tumors?
    Elham Mehranzadeh, Olatz Crende, Iker Badiola, Patricia García-Gallastegui · 2022 · Biomedicines
  69. Development of a TGF-β signaling-related genes signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma
    Xin Wu, Wenjie Xie, Binbin Gong, Bin Fu, Wei-Min Chen, Libo Zhou, Lianmin Luo · 2023 · Frontiers in Oncology
  70. Dichloroacetate modulates cytokines toward T helper 1 function via induction of the interleukin-12–interferon-γ pathway
    Khalid Z. Matalka, Mujtaba Badr, Nidal Adel Qinna, Fadi Qadan · 2014 · OncoTargets and Therapy
  71. Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status
    Yuhui Zhang, Zhuoming Liu · 2019 · Current Pharmaceutical Design
  72. Case Report: Immune and Genomic Characteristics Associated With Hyperprogression in a Patient With Metastatic Deficient Mismatch Repair Gastrointestinal Cancer Treated With Anti-PD-1 Antibody
    Wenyue Zhou, Yuwen Zhou, Yi Cheng, Xinyao Shu, Gui-Xia Wei, Xiaorong Chen, Xudong Shen, Meng Qiu · 2021 · Frontiers in Immunology
  73. Dominant negative TGF-β receptor type II in T lymphocytes promotes anti-tumor immunity by modulating T cell subsets and enhancing CTL responses
    Hao Ming Li, Yanling Guan, Chenchen Han, Yu Zhang, Yizhao Chen, Li‐Ping Jiang, Pingping Zhang, Xiu Chen, Wei Wei, Yang Ma · 2022 · Biomedicine & Pharmacotherapy
  74. Using Pharmacokinetic–Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from Panax ginseng–Ophiopogon japonicus
    Lu Liu, Jing Lyu, Longfei Yang, Yan Nan Gao, Bonian Zhao · 2024 · Molecules
  75. Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
    Jeffrey How, Minghao Dang, Sanghoon Lee, Bryan M. Fellman, Shannon Neville Westin, Anil K. Sood, Nicole D. Fleming, Aaron Shafer, Ying Yuan, Jinsong Liu et al. · 2024 · Med
  76. Mathematical model of tumor immune microenvironment with application to the combined therapy targeting the PD-1/PD-L1 pathway and IL-10 cytokine antibody
    Zixin Zhang, Xiyin Liang, Jianyong Qin, Jinzhi Lei · 2024 · Theory in Biosciences
  77. Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma
    Roghayeh Naserkhaki, Bahareh Shokouhian, Yaser Tahamtani, Arezoo Khosravi, Siavash Iravani, Ali Zarrabi, Massoud Vosough · 2025 · BME Frontiers
  78. Spatial Profiling Identifies Tumor-Associated Stroma Enrichment and MIF as Potential Immunotherapy Targets in Primary Ewing Sarcomas
    Christopher Kuo, Krinio Giannikou, N.-K. Wang, Mikako Warren, Andrew E. Goodspeed, Nick Shillingford, Masanori Hayashi, Micha Sam Brickman Raredon, James F. Amatruda · 2025 · Clinical Cancer Research
  79. Radiation-induced increases in cancer mortality result from an earlier onset of the disease in mice and atomic bomb survivors
    Nori Nakamura · 2022 · International Journal of Radiation Biology
  80. Advancements in nanomedicine delivery systems: unraveling immune regulation strategies for tumor immunotherapy
    Yi Zhang, Xi Chen, Binbin Hu, Bingwen Zou, Yong Xu · 2024 · Nanomedicine
  81. microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy
    Gilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, Ettai Markovits, Rona Ortenberg, Ronnie Shapira-Fromer, Orit Itzhaki, Jacob Schachter, Michal Judith Besser, Gal Markel · 2020 · Cancer Immunology Immunotherapy
  82. MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway
    Run Xu, Xuemei Zhou, Yushan Li, Li Ren, Xin-Rong He · 2021 · Molecular Medicine Reports
  83. Immune Modulatory Effects of Molecularly Targeted Therapy and Its Repurposed Usage in Cancer Immunotherapy
    Tiancheng Zhang, Chenhao Zhang, Zile Fu, Qiang Gao · 2022 · Pharmaceutics
  84. Analysis of genomes and transcriptomes of clear cell renal cell carcinomas identifies mutations and gene expression changes in the TGF-beta pathway
    Xiangyu Che, Jianyi Li, Yingkun Xu, Qifei Wang, Guangzhen Wu · 2022 · Frontiers in Genetics
  85. PARP1 controls the transcription of CD24 by ADP-ribosylating the RNA helicase DDX5 in pancreatic cancer
    Kang Chen, Manxiong Dai, Quanneng Luo, Yi Wang, Weitao Shen, Yan Liao, Yiying Zhou, Wei Cheng · 2022 · The International Journal of Biochemistry & Cell Biology
  86. Effects of metalloprotease ADAMTS12 on cervical cancer cell phenotype and its potential mechanism
    Ruanmin Zou, Ruihong Gu, Xinyu Tu, Jiani Chen, Songjun Liu, Xiangyang Xue, W Li, Yuyang Zhang · 2023 · Discover Oncology
  87. Tumor microenvironment dynamics in oral cancer: unveiling the role of inflammatory cytokines in a syngeneic mouse model
    Ayano Tobe‐Nishimoto, Yoshihiro Morita, Junya Nishimura, Yukiko Kitahira, Shun Takayama, Satoko Kishimoto, Yuka Matsumiya, Kazuhide Matsunaga, Tomoaki Imai, Narikazu Uzawa · 2024 · Clinical & Experimental Metastasis
  88. Crosstalk Between Macrophages and Breast Cancer Cells: Networking Within Tumors
    Pooja Kamal Melwani, Rahul Checker, Murali Mohan Sagar Balla, Badri Narain Pandey · 2024 · Results and problems in cell differentiation
  89. Clinical and immunological characteristics of high-risk double-hit multiple myeloma
    Yufeng Shang, Guopeng Chen, Li Liu, Ruiyang Pan, Xinqi Li, Hui Shen, Yuxin Tan, Linlu Ma, Xiqin Tong, Weida Wang et al. · 2024 · BMC Cancer
  90. IL17A/F secreted by ASCT2-overexpression ovarian cancer cells contributes to immune escape through the suppression of natural killer (NK) cells cytotoxicity by the activation of c-JUN/ PTGS2 pathway
    Huixiang Zhang, Haohan Li, Yanyan Qi, Junhan He, Li Deng, Shipu Chen, Hong Pan, Huiming Guo · 2025 · International Immunopharmacology
  91. Early-life dietary exposures mediate persistent shifts in the gut microbiome and visceral fat metabolism
    Tiffany M. Newman, Kenysha Y.J. Clear, Adam S. Wilson, David R. Soto‐Pantoja, Heather M. Ochs‐Balcom, Katherine Loree Cook · 2022 · American Journal of Physiology-Cell Physiology
  92. Comprehensive landscape of m6A regulator-related gene patterns and tumor microenvironment infiltration characterization in gastric cancer
    Bin Peng, Yinglin Lin, Yi Gao, Mingzhen Lin, Yao Xiao, Yezhenghong Qiu, Wenxia Yao, Xinke Zhou, Zhaoyu Liu · 2024 · Scientific Reports
  93. Enhancing antitumor immunity: the role of immune checkpoint inhibitors, anti-angiogenic therapy, and macrophage reprogramming
    Chong Zhang, Hua Wang, Xinying Li, Yuxin Jiang, Guoping Sun, Hanqing Yu · 2025 · Frontiers in Oncology
  94. Recombinant viruses with other anti-cancer therapeutics: a step towards advancement of oncolytic virotherapy
    Geetanjali Lal, Maitreyi S. Rajala · 2018 · Cancer Gene Therapy
  95. Skeletal Deformities in Osterix-Cre;Tgfbr2f/f Mice May Cause Postnatal Death
    Kara N. Corps, Monica Stanwick, Juliann Rectenwald, Andrew Kruggel, Sarah B. Peters · 2021 · Genes
  96. Ginger mitigated the health risks associated with arsenic-contamination of rats feed via inflammatory and apoptosis regulation
    Adewale Adetutu, Abiodun Bukunmi Aborisade, Faith Ayotunde Ogunsina, Peter Ifeoluwa Adegbola, Temitope Deborah Olaniyi · 2023 · Ecotoxicology and Environmental Safety
  97. Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene‐modified allogeneic tumor cell vaccine in advanced renal cell cancer: Tumor‐induced immunosuppression and a possible role for NF ‐κ B
    Anne Flörcken, Michael Grau, Annette Wolf, André Weilemann, Joachim Kopp, Bernd Dörken, Thomas J. F. Blankenstein, Antonio Pezzutto, Peter Lenz, Georg Lenz et al. · 2014 · International Journal of Cancer
  98. A preliminary Study on the Effect of Head and Neck Chemoradiotherapy on Systematic Immunity
    Weiqiang Huang, Yao Fan, Xiaoya Cheng, Huazhen Liang, Hua Pan, Ting Xiao, Min Chen, Jian Guan · 2019 · Dose-Response
  99. Establishing a Link Between Endothelial Cell Metabolism and Vascular Behaviour in a Type 1 Diabetes Mouse Model
    Carolina Silva, Vasco Sampaio‐Pinto, Sara Andrade, Ilda Rodrigues, Raquel Costa, Susana G. Guerreiro, Eugénia Carvalho, Perpétua Pinto‐do‐Ó, Diana Santos Nascimento, Raquel A. Soares · 2019 · Cellular Physiology and Biochemistry
  100. Effect of cytokines on NK cell activity and activating receptor expression in high-risk cutaneous melanoma patients
    Katarina Mirjačić Martinović, Milica Milićević, Annette Kragh Larsen, Radan R Džodić, Vladimir Jurišić, Gordana M. Konjević, Ana M. Vuletić · 2019 · European Cytokine Network